Despite reporting a 37% growth in net profit to Rs 271 crore for the March quarter, the stock of private lender RBL Bank fell 4.4% to Rs 154.6 in Tuesday's trade. In the same quarter, core net interest income grew 7% to Rs 1,211 crore on the back of a 17% rise in advances. Analysts have maintained a Hold rating with a target price of Rs 170, downgraded the stock to Neutral with a target price of Rs 185, and recommended a Buy with target prices of Rs 194 and Rs 195 for RBL Bank's shares.

A total of 578,695 shares changed hands on the counter till 11:43AM (IST).

The stock quoted a 52-week high of Rs 608.65 and a 52-week low of Rs 380.95.

The Relative Strength Index of the stock stood at 60.79 on Tuesday.

A total of 4,428 shares changed hands on the counter till 11:28AM (IST)

The Nifty Pharma index was trading 0.08 per cent down at 12604.1.

The stock quoted a 52-week high of Rs 2194.0 and a 52-week low of Rs 1513.3.

The Nifty Bank index was trading 0.43 per cent up at 43421.9.